The NeuroStar® TMS Therapy System is the first TMS device cleared by the U.S. Food and Drug Administration (FDA) for the treatment of patients with Major Depressive Disorder who have not benefited from prior antidepressant treatment. NeuroStar TMS Therapy uses highly a focused, pulsed magnetic field to stimulate function in targeted brain regions.
TMS therapy is:
- Non-invasive, meaning it does not involve surgery, anesthesia, or sedation, as the patient remains awake and alert during the treatment.
- Non-systemic, meaning that it is not taken by mouth and does not circulate in the bloodstream throughout the body.
To schedule an appointment or for more information about how SCTMSC and TMS Therapy might be a good fit for you, please visit our NEXT STEP page.